Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

NCT06132360 ·Status: COMPLETED ·Phase: PHASE1

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

NCT00810979 ·Status: COMPLETED ·Phase: PHASE2

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

NCT01763918 ·Status: COMPLETED ·Phase: PHASE3

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

NCT02087917 ·Status: COMPLETED ·Phase: PHASE2

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

NCT05905068 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia

NCT01266876 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

NCT07037771 ·Status: RECRUITING ·Phase: PHASE3

Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity

NCT05632068 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

NCT00562575 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects

NCT06573528 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects

NCT06485245 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

NCT02265952 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects

NCT01785329 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

NCT03413462 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

NCT02585778 ·Status: COMPLETED ·Phase: PHASE3

A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)

NCT01583647 ·Status: TERMINATED ·Phase: PHASE1

Study to Test GSK256073 in Patients With Dyslipidemia

NCT00903617 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

NCT05621070 ·Status: RECRUITING ·Phase: PHASE3

Lipid Efficacy/Tolerability Study (0524A-020)

NCT00269204 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

NCT06925100 ·Status: COMPLETED ·Phase: PHASE4

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

NCT04874129 ·Status: UNKNOWN ·Phase: PHASE1

A Second Study to Determine the Effect of GSK256073A on HVTs

NCT00551694 ·Status: COMPLETED ·Phase: PHASE1

An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism

NCT00847782 ·Status: COMPLETED ·Phase: NA

Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study

NCT01375751 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

NCT02676596 ·Status: COMPLETED ·Phase: PHASE1